136572-09-3

  • Product Name:Irinotecan Hydrochloride
  • Molecular Formula:C33H45ClN4O9
  • Molecular Weight:677.195
  • Appearance:Pale yellow to yellow crystalline powder
Inquiry

Product Details

pd_meltingpoint:250-256 °C (dec.)

Appearance:Pale yellow to yellow crystalline powder

Purity:99%

Chinese Manufacturer Supply Irinotecan Hydrochloride 136572-09-3 On Stock with Competitive Price

  • Molecular Formula:C33H45ClN4O9
  • Molecular Weight:677.195
  • Appearance/Colour:Pale yellow to yellow crystalline powder 
  • Melting Point:250-256 °C (dec.) 
  • Boiling Point:873.4 °C at 760 mmHg 
  • Flash Point:482 °C 
  • PSA:141.89000 
  • Density:== 
  • LogP:4.57600 

Irinotecan hydrochloride trihydrate(Cas 136572-09-3) Usage

Hazard

Moderately toxic by ingestion.

Definition

ChEBI: A hydrate that is the trihydrate form of irinotecan hydrochloride. Onivyde is used in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active.

Brand name

Camptosar (Pharmacia &Upjohn) .

InChI:InChI=1/C33H38N4O6.ClH/c1-3-22-23-9-8-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)16-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1

136572-09-3 Relevant articles

Synthesis method of irinotecan hydrochloride

-

Paragraph 0026-0028, (2021/07/17)

The invention discloses a synthesis meth...

PREPARATION METHOD

-

Page/Page column 6, (2008/06/13)

The present invention is directed to a n...

136572-09-3 Process route

irinotecan hydrochloirde
100286-90-6

irinotecan hydrochloirde

irinotecan hydrochloride trihydrate
136572-09-3

irinotecan hydrochloride trihydrate

Conditions
Conditions Yield
With hydrogenchloride; water; In ethanol; at 75 - 80 ℃;
87%
With water; In ethanol; Heating / reflux;
4-piperidinopiperidine-1-carbonyl chloride
103816-19-9

4-piperidinopiperidine-1-carbonyl chloride

7-ethyl-10-hydroxycamptothecin
86639-52-3,110714-48-2,130144-34-2,113015-38-6,647852-82-2

7-ethyl-10-hydroxycamptothecin

irinotecan hydrochloride trihydrate
136572-09-3

irinotecan hydrochloride trihydrate

Conditions
Conditions Yield
4-piperidinopiperidine-1-carbonyl chloride; 7-ethyl-10-hydroxycamptothecin; With potassium carbonate; In pyridine; dichloromethane; at 20 ℃; for 6h;
With hydrogenchloride; In pyridine; dichloromethane; water;
90%

136572-09-3 Upstream products

  • 100286-90-6
    100286-90-6

    irinotecan hydrochloirde

  • 103816-19-9
    103816-19-9

    4-piperidinopiperidine-1-carbonyl chloride

  • 86639-52-3
    86639-52-3

    7-ethyl-10-hydroxycamptothecin

Relevant Products